Clinical Research of Blood CsA C2 Level Monitoring in Renal Allograft Recipients

XU Da,WANG Xiang-hui,ZHOU Pei-jun,CHU Chen-long
DOI: https://doi.org/10.3969/j.issn.1674-8115.2006.06.030
2006-01-01
Abstract:Objective To decrease the incidence of acute rejection in renal allograft recipients by monitoring of cyclosporine A (CsA) concentration at 2-hour after dosing(C2). Methods The CsA C2 and CsA trough concentration(C0) were assayed in renal allograft recipients.All patients were followed up for at least 1 year.The correlation of C0 and C2 monitoring with clinical outcomes was analyzed. Results At 1 week and 1 month post-transplantation,the incidence of acute rejection in patients with C2 in target level was 4.41% and 10.29%, respectively,but the incidence of acute rejection in patients with C2 in lower level was 42.37% and 36.20%,respectively. ConclusionBy reflecting the drug exposure of CsA more accurately,C2 monitoring is beneficial for decreasing the incidence of acute rejection after renal allograft transplantation.
What problem does this paper attempt to address?